Market watchers been eyeing economic data, the Fed and low oil prices to predict the odds of a recession, these experts share their insight.» Read More
Larry Robbins of Glenview Capital unveiled four new stock picks at the Robin Hood Investors conference Tuesday.
Where many investors saw turmoil in the stock market over the past few weeks, David Einhorn saw opportunity.
Spare a thought for Warren Buffett, whose portfolio is not doing him any favors this week.
Is the worst of the market carnage over? Ron Insana looks at what technical indicators are saying.
A number of old-school industrial companies and and multi-industry conglomerates have given investors something to cheer about with upbeat guidance.
When the S&P has fallen 5 percent in October after hitting a 12-month high in September, a sweet end to the year has tended to follow.
McDonald's "benchmark bad quarter" will likely warrant major changes at the fast food giant, says CNBC's Jim Cramer.
"The financial industry has largely lost the public trust," New York Fed President William Dudley said.
Lockheed Martin on Tuesday reported net income of $888 million in its third quarter.
The Travelers Cos. on Tuesday reported third-quarter earnings of $919 million.
Hedge funds designed to profit from choppy and down markets have mostly underwhelmed in October.
Some of the names on the move ahead of the open.
Asked if he'd want his old job back, Mohamed El-Erian tells CNBC: "No, I'm really happy with my life."
The Bank of England has launched a "thorough" and "independent" investigation into what caused a 10-hour crash of the U.K.'s interbank payment system Monday which halted high value payments such as house purchases.
After Cramer called bottom on Friday, investors are circling back to Apple and leaving IBM behind. Cramer also picks his winners for the long run.
China's third quarter gross domestic product report delivered an upside surprise, helping calm investor nerves over the faltering global recovery.
United Technologies posted a rise in quarterly profit, helped by a tax settlement and earnings increases across its aerospace and commercial building segments.
AbbVie is walking away from its proposed $55 billion takeover bid of Shire and has agreed to pay the rival drugmaker a $1.64 billion breakup fee.
Lew said recent movements of the euro versus the dollar seem linked more to differences in growth than policies aimed at depreciating the Euro.
When the bond-fund heavyweight Pimco scuffles with passive investing guru John Bogle, it's like watching a good prize-fight boxing match.